Patient characteristic | High dose (n = 21) | Usual care (n = 20) |
---|---|---|
Age (months), median (IQR) | 4.6 (1.0–45.6) | 3.8 (0.8–35.6) |
Weight (kg), median (IQR) | 5.4 (4.2–13.4) | 5.8 (3.6–12.9) |
Male sex, n (%) | 10 (47.6%) | 13 (65.0%) |
Enrolment location, n (%) | ||
 Cardiology | 15 (71.4%) | 15 (75.0%) |
 NICU | 4 (19.0%) | 5 (25.0%) |
 PICU | 2 (9.5%) | 0 (0.0%) |
Surgery season, n (%) | ||
 Winter | 6 (28.6%) | 5 (25.0%) |
 Spring | 3 (14.3%) | 2 (10.0%) |
 Summer | 6 (28.6%) | 8 (40.0%) |
 Fall | 6 (28.6%) | 5 (25.0%) |
RACHS, median (IQR) | 2 (2–3) | 3 (2–4) |
Ethnicity, n (%) | ||
 Caucasian | 14 (66%) | 14 (70.0%) |
 Aboriginal | 1 (5%) | 1 (5.0%) |
 Asian | 0 (0%) | 3 (15.0%) |
 African/West Indian | 2 (10%) | 1 (5.0%) |
 Unknown or others | 4 (19%) | 1 (5.0%) |
Other active medical conditions, n (%) | 7 (33.3%) | 7 (35.0%) |
 Genetic | 5 (71.4%) | 3 (42.9%) |
 Chronic lung | 1 (14.3%) | 2 (28.6%) |
 Endocrine | 1 (14.3%) | 1 (14.3%) |
 Others | 3 (42.9%) | 4 (57.1%) |
Expected time to surgery at enrolment, n (%) | ||
 < 2 months | 18 (86%) | 18 (90%) |
 > 2 months | 3 (14%) | 2 (10%) |
Children ≤ 1 year, n (%) | ||
 Breastfed | 10 (83%) | 9 (75%) |
 Formula-fed | 2 (17%) | 3 (25%) |